Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-18

Clinical Trial Update: A Prospective, Multicenter, Single Arm Feasibility Study of the Safety and Performance of GRADION™ Hip Total Cartilage Replacement (TCR)™ in the Treatment of Degenerative Joint Disease of the Hip [NA]

View source ↗

Summary

A prospective, multicenter feasibility trial evaluating the safety and performance of the GRADION Hip Total Cartilage Replacement for osteoarthritis of the hip …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GRADION Hip Total Cartilage Replacement (TCR)

Snippet

Sponsor: Biomimedica, Inc | Conditions: Degenerative Joint Disease of the Hip | NA | Status: TERMINATED